| Trial ID: | L6017 |
| Source ID: | NCT01799850
|
| Associated Drug: |
Pioglitazone
|
| Title: |
The Impact of Actos Treatment of Diabetes on Glucose Transporters in Muscle
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Type 2
|
| Interventions: |
DRUG: Pioglitazone|DRUG: placebo
|
| Outcome Measures: |
Primary: change in muscle glucose transporter expression, immunoblots pre and post, placebo and Actos, post eight weeks treatment |
|
| Sponsor/Collaborators: |
Sponsor: East Tennessee State University | Collaborators: Takeda Pharmaceuticals North America, Inc.
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
12
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2002-03
|
| Completion Date: |
2004-03
|
| Results First Posted: |
|
| Last Update Posted: |
2013-02-27
|
| Locations: |
ETSU Quillen College of Medicine, Johnson City, Tennessee, 37614, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT01799850
|
